About this document
Patient-Centric Diabetes Management by han bopa is a document available to read on EtoBox.
The ADA standards for diabetes treatment have evolved to emphasize earlier use of GLP-1 RAs and SGLT2 inhibitors due to their proven cardiovascular benefits. The 2023 standards recommend these medications for patients with diabetes and cardiovascular disease independent of A1C or metformin use.
- Author
- han bopa
- Language
- EN